A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Acon Biotech (Hangzhou) Co., Ltd.
China · 4 relevant products
ACON Laboratories, Inc.
United States · 1 relevant product
Clinomics Europe Kft.
Hungary · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 10 relevant products
FUJIFILM Healthcare Americas Corporation
United States · 3 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
STRATEC/Diatron
Germany · 2 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
CheMOnitor Ltd.
Hungary · 1 relevant product
46 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 93 closest product alternatives
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
Gene methylation-based diagnostic test for early detection of hepatocellular carcinoma with industry-leading performance metrics. This blood-based test enables non-invasive screening for liver cancer risk stratification. The product is approved by NMPA and integrated into multiple hospital and insurance systems.
FUJIFILM Healthcare Americas Corporation · United States
Comprehensive in vitro diagnostic test system for hepatocellular carcinoma risk assessment in patients with chronic liver disease. Integrates AFP-L3 and DCP biomarker testing for improved early detection.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
PreceDo Pharmaceuticals Co.Ltd. · China
Genetic screening for hereditary cancer susceptibility genes including BRCA and other tumor suppressors. This test enables early identification of high-risk individuals for surveillance.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
BioChain (Beijing) Science & Technology. Inc. · China
Biomarker-based diagnostic test for early detection and screening of diabetes mellitus. This test supports the company's focus on early identification and intervention in metabolic diseases. The product is part of comprehensive chronic disease screening offerings.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for prenatal screening and fetal abnormality detection. Assesses risk for genetic and chromosomal disorders.
HLB PANAGENE Co., Ltd. · South Korea
A molecular screening test for human papillomavirus detection in clinical samples supporting cervical cancer prevention programs.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products